A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT04673357 · COMPLETED
Trial details
- NCT number
- NCT04673357
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-06
- Primary completion
- 2024-11-28
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.